credit facility
Atara Biotherapeutics Receives FDA Complete Response Letter for Ebvallo
The FDA didn't approve the therapy in EBV-positive posttransplant lymphoproliferative disease due to findings at a third-party manufacturing facility.
Ocugen Obtains $30M Credit Facility
The company will use the proceeds to develop its gene therapies for eye disorders and for general corporate expenses.